Patent ID: 11912777
Assignee: NANJING LEADS BIOLABS CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 5:
6. The anti-TNFR2 antibody or the antigen-binding fragment thereof according to claim 1, which further comprises a heavy chain constant region, or a light chain constant region, wherein
the heavy chain constant region
(i) is or is derived from a human IgG1, IgG2, IgG3 or IgG4 constant region;
(ii) comprises an amino acid sequence having at least 90% identity to the amino acid sequence of SEQ ID NO: 40 or SEQ ID NO: 73; or
(iii) comprises the amino acid sequence of SEQ ID NO: 40 or SEQ ID NO:73;
or
the light chain constant region
(i) is or is derived from human kappa or lambda light chain constant region,
(ii) comprises an amino acid sequence having at least 90% identity to the amino acid sequence of SEQ ID NO: 42; or
(iii) comprises the amino acid sequence of SEQ ID NO: 42.